Eligibility for anti-TNFα therapy in a psoriatic arthritis out patient cohort

被引：0
|
作者：
Kyle, SD [1 ]
Solanki, K [1 ]
Carmichael, C [1 ]
McHugh, NJ [1 ]
机构：
[1] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England
来源：
RHEUMATOLOGY | 2005年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
272
引用
收藏
页码：I114 / I114
页数：1
相关论文
共 50 条
  • [21] Varicella zoster virus encephalopathy in a patient with psoriatic arthritis treated with anti-TNFα agents
    Miyagi, Takuya
    Yamaguchi, Sayaka
    Yamamoto, Yu-ichi
    Ohira, Aoi
    Yasumura, Ryo
    Nakasone, Naoko
    Uezato, Hiroshi
    Takahashi, Kenzo
    EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (03) : 398 - 399
  • [22] Complex Role of TNF Variants in Psoriatic Arthritis and Treatment Response to Anti-TNF Therapy: Evidence and Concepts
    Hueffmeier, Ulrike
    Moessner, Rotraut
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (10) : 2483 - 2485
  • [23] A cost efficacy analysis of anti-TNF therapy in psoriatic arthritis using PASI scores
    Arjunji, R.
    Rahman, M.
    Dabbous, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 274 - 274
  • [24] PROGRESSION OF FUNCTIONAL DISABILITY IN PSORIATIC ARTHRITIS: A COMPARISON OF CONVENTIONAL DMARDS AND ANTI-TNF THERAPY
    Gingold, Michael J.
    Bansback, Nick
    Guh, Daphne P.
    Cavill, Charlotte
    Porteous, Rebecca
    Kyle, Stuart D.
    Waldron, Nicola
    Korendowych, Eleanor
    McHugh, Neil
    RHEUMATOLOGY, 2010, 49 : I59 - I59
  • [25] DIFFERENTIAL SERUM GLYCOSYLATION CHANGES IN RHEUMATOID AND PSORIATIC ARTHRITIS - IN RESPONSE TO ANTI-TNF THERAPY
    Alavi, Azita
    Fitzgerald, Oliver
    Collins, Emily S.
    Fraser, Owen
    Tarelli, Edward
    Ng, Vincent C.
    Breshnihan, Barry
    Veale, Douglas J.
    Axford, John S.
    RHEUMATOLOGY, 2010, 49 : I105 - I106
  • [26] Biologic therapies different from the anti-TNF alpha therapy in psoriasis and psoriatic arthritis
    Queiro Silva, Ruben
    Alonso Castro, Sara
    Ballina Garcia, Javier
    REUMATOLOGIA CLINICA, 2010, 6 : 41 - 46
  • [27] Wnt pathway inhibitors in patients with psoriatic and rheumatoid arthritis treated with anti-TNF therapy
    Szentpetery, A.
    Bhattoa, H. P.
    Antal-Szalmas, P.
    Szekanecz, Z.
    FitzGerald, O.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S105 - S106
  • [28] Wnt Pathway Inhibitors in Patients with Psoriatic and Rheumatoid Arthritis Treated with Anti-TNF Therapy
    Szentpetery, Agnes
    Bhattoa, Harjit P.
    Antal-Szalmas, Peter
    Szekanecz, Zoltan
    FitzGerald, Oliver M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S236 - S237
  • [29] PERSISTENCY WITH SUBCUTANEOUS ANTI-TNF THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Waters, H.
    Olson, W.
    Bolge, S.
    Gunnarsson, C.
    VALUE IN HEALTH, 2012, 15 (04) : A41 - A41
  • [30] ADALIMUMAB IN PSORIATIC ARTHRITIS WHEN OTHER ANTI-TNF FAIL
    Lopez-Moyado, A. L.
    Cervantes-Solano, J., I
    Rodrigues-Tamariz, W. L.
    Banuelos-Ramirez, D.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S73 - S74
12345